The Navifus System has been getting a clinical trial approval for Drug-Resistant Epilepsy in Taiwan

by NaviFUS
in 2019
on 20/02/2019

NaviFUS announced that their focus ultrasound system (NaviFUS system) had gotten the clinical trial approval from TFDA for the treatment of drug-resistant epilepsy(DRE). The primary goal of this trial is validation the safety of NaviFUS system using in DRE. Subjects recruiting will start in April…